 |
 |
 |
 |
 |
 |
 |
Member Information
Rob Roy MacGregor, MD
Professor, Infectious Diseases
Office Phone: 215-662-3565
Office Fax: 215-349-8011
Email: macgregr@mail.med.upenn.edu
Website(s):
Education: MD 1964, Harvard University
Keywords: Opportunistic infections, HIV vaccines, drug pharmacokinetics
Research and/or Clinical Interests:
Current research involves V-Z vaccination of HIV-infected subjects; use of DNA-based HIV vaccines as therapy; examination of dapsone PK behavior in renal failure; PI for several ACTG trials. Clinical work involves in-patient and out-patient management of HIV-infected patients in the Division of Infectious Diseases at HUP.
Summary:
See above.
Representative Publications:
MacGregor RR, Ginsberg R, Ugen KE, Baine Y, Kang C, Tu XM, Higgins T, Weiner DB, Boyer JD: T-cell responses induced in normal volunteers immunized with a DNA based vaccine containing HIV-1 env and rev. AIDS 2002;16:2137-43.
Aberg JA, Williams PL , Liu T, Lederman HM, Hafner R, Torriani F, Lennox JL, Dube MP, MacGregor RR, Currier JS: A study of discontinuing maintenance therapy in HIV-infected subjects with disseminated Mycobacterium avium complex (DMAC): ACTG 393 Study Team. J Infec Dis 2003;187:1046-52.
MacGregor RR, Hafner R, Wu J, Murphy RL, Perlman DC , Bermudez LE, Inderlied CB, Picker LJ, Wallis RS, Andersen JW, Mahon 1 LF, Koletar SL, Peterson DM, and the ACTG Protocol 341 Team: Immunological, microbiological, and clinical characteristics in HIV-snfected subjects at risk for disseminated M. avium complex disease: An AACTG Study (submitted)
